How to deal with the different challenges in your professional career YO Session

How to deal with social media - Self-representation and networking (ID 29)

Lecture Time
17:50 - 18:00
Speakers
  • D. S. Dizon (Providence, United States of America, RI)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05
How to deal with the different challenges in your professional career YO Session

How to start an international collaboration - Developing and integrating research in clinical practice (ID 30)

Lecture Time
18:00 - 18:10
Speakers
  • M. Mirza (Copenhagen, Denmark)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05
Authors
  • M. Mirza (Copenhagen, Denmark)
How to deal with the different challenges in your professional career YO Session

How to seize opportunities and progress your career in the gynae-oncology field (ID 31)

Lecture Time
18:10 - 18:20
Speakers
  • C. Sessa (Bellinzona, Switzerland)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05
Authors
  • C. Sessa (Bellinzona, Switzerland)
How to deal with the different challenges in your professional career YO Session

Live Q&A and discussion (ID 32)

Lecture Time
18:20 - 19:05
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Fri, 25.06.2021
Time
17:50 - 19:05
Best of abstracts session Abstract session

Long term safety and secondary efficacy end points in the ENGOT-OV16/NOVA phase 3 trial on Niraparib in recurrent ovarian cancer (ID 24)

Lecture Time
12:55 - 13:05
Speakers
  • M. Mirza (Copenhagen, Denmark)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session Abstract session

Live Q&A and discussion (ID 25)

Lecture Time
13:15 - 13:30
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session Abstract session

Rucaparib vs chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: Efficacy and safety from ARIEL4, a randomized phase 3 study (ID 26)

Lecture Time
13:30 - 13:40
Speakers
  • R. Kristeleit (London, United Kingdom)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session Abstract session

Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo (pbo)-controlled randomised phase III trial of bevacizumab (bev)-containing therapy +/- atezolizumab (atezo) for newly diagnosed stage III/IV ovarian cancer (OC) (ID 27)

Lecture Time
13:40 - 13:50
Speakers
  • K. N. Moore (Oklahoma City, United States of America, Oklahoma)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session Abstract session

Discussion (ID 33)

Lecture Time
13:50 - 14:00
Speakers
  • S. Banerjee (London, United Kingdom)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session Abstract session

Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation (ID 12)

Lecture Time
12:45 - 12:55
Speakers
  • A. Poveda Velasco (Valencia, Spain)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session Abstract session

Live Q&A and discussion (ID 28)

Lecture Time
14:00 - 14:15
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15
Best of abstracts session Abstract session

Discussion (ID 34)

Lecture Time
13:05 - 13:15
Speakers
  • E. C. Kohn (Bethesda, United States of America)
Location
Channel 1, Virtual Meeting, Vienna, Austria
Date
Sat, 26.06.2021
Time
12:45 - 14:15